|

Use Misoprostol to Optimize Prevention of Cervical Cancer

RECRUITINGN/ASponsored by University of Alabama at Birmingham
Actively Recruiting
PhaseN/A
SponsorUniversity of Alabama at Birmingham
Started2025-02-25
Est. completion2026-11-04
Eligibility
Age25 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06669533

Summary

This is a double-blind randomized controlled trial of 420 non-pregnant women undergoing cancer screening by visual inspection with acetic acid (VIA) who have Type 3 transformation zone (TZ) and randomized to receive either Misoprostol or placebo.

Eligibility

Age: 25 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Diagnosis of Type 3 TZ confirmed on exam prior to randomization
* Age 25 years or older

Exclusion Criteria:

* With Type 1 or 2 TZ prior to randomization
* Currently pregnant
* History of hysterectomy
* Any cancerous lesions
* Active cervicitis

Conditions2

CancerCervical Cancers

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.